Glycogen storage disease type 3 (Cori disease)
On ABGC's listListed on the ABGC Self-Study GuideLog in to starLast updated Nov 10, 2026
A child with hepatomegaly has fasting hypoglycemia similar to GSD1 but responds to glucagon and has elevated CK due to myopathy.
AR; AGL (glycogen debranching enzyme). Biallelic loss-of-function variants, with nonsense, frameshift, and splice variants overrepresented; IIIa affects liver and muscle, IIIb liver only.
Between meals, glycogen phosphorylase clips glucose off the outer chains of glycogen until four residues remain before each branch point. The debranching enzyme then does two jobs: its transferase moves three of those residues onto the parent chain, and its 1,6-glucosidase cuts the branch, releasing free glucose. Without it, breakdown stops at the branches: glycogen cannot be fully degraded, and an abnormal glycogen with short outer branches, limit dextrin, accumulates. That explains hepatomegaly and ketotic fasting hypoglycemia; unlike GSD I, lactate and uric acid are usually normal.
Isoform use explains the two subtypes:
- GSD IIIa (about 85%): the enzyme is missing in liver and muscle, adding skeletal myopathy and cardiomyopathy with raised CK.
- GSD IIIb (about 15%): two truncating variants in exon 3 (c.16C>T, c.18_19delGA) cause liver-only disease. Muscle keeps normal enzyme, probably because its isoforms can start translation at a downstream codon that bypasses exon 3.
Outside exon 3 there is no firm genotype-phenotype correlation, though truncating variants may go with severe disease. A high-protein diet with no excess carbohydrate can improve the skeletal and cardiac myopathy.
Part of glycogen synthesis and breakdown.
Glycogen degradation, the branch-point step in liver and muscle.
glycogen → glycogen phosphorylase → glucose-1-phosphate from outer chains, until 4 residues remain at each branch → debranching enzyme (the block; transferase and 1,6-glucosidase) → free glucose and a straight chain for phosphorylase
- Accumulates: limit dextrin (abnormal short-branched glycogen) in liver and muscle; the lab sees raised transaminases and CK, and ketones on fasting.
- Missing: glucose released from the inner, branched glycogen, so fasting brings ketotic hypoglycemia.
- Workbook: 6.C. Hepatic glycogen storage diseases
- Hepatomegaly, hypoglycemia (milder than GSD1)
- Responds to glucagon (unlike GSD1)
- Myopathy, cardiomyopathy
- Elevated CK
- Liver disease improves with age
- Not on RUSP; suspected from hepatomegaly with ketotic fasting hypoglycemia plus elevated CK
- Elevated transaminases, CK; ketotic hypoglycemia (contrast with GSD1: no lactic acidosis, normal/low uric acid)
- Confirmation: biallelic AGL variants (largely supplanted enzyme/biopsy testing); abnormal limit dextrins on glycogen analysis if tissue obtained
- Frequent feeding with cornstarch to prevent hypoglycemia
- High-protein diet (supports gluconeogenesis; supplies muscle substrate)
- Cardiac and hepatic surveillance (cardiomyopathy, rare cirrhosis/adenomas)
"III" looks like tree branches: GSD III is the debranching enzyme deficiency. Think of a coral reef with branches. Also, 3 x 2 = 6 (alpha-1,6-glucosidase).
Milder von Gierke: GSD III is a milder version with hepatomegaly + hypoglycemia (like GSD1), but gluconeogenesis is intact, so no lactic acidosis. Has myopathy (unlike GSD1, which has no time to develop muscle issues).
Limit dextrins accumulate: the debranching enzyme removes 1,6-linked glucose residues. Without it, branched glycogen fragments (limit dextrins) build up.